Energy Ink achieves key step toward global collaboration

Share

This achievement establishes the foundations for collaboration with international printed electronics centres and potential end-users. Through these partnerships, Energy Ink may be evaluated and co-developed into prototype cells and product demonstrators within industrial-style facilities. Building this capability broadens the opportunity base and creates a clear pathway from research conducted in Australia to active engagement with global industry.

Transfer Program Outcomes

Over 2,000 prototype Energy Ink cells were successfully fabricated in a single production run and validated, confirming reproducibility in a commercial facility. In addition, 30 multi-cell arrays were connected and operated continuously for seven days at the target baseline power.

Fabrication in a commercial facility

Energy Ink cells demonstrating reproducibility under industrial processes.

High Yield Achieved

2,051 of 2,052 cells (99.95%) passed compliance testing for open-circuit voltage and short-circuit current.

Connected arrays manufactured

Successfully validated that interconnected cells can operate as functional arrays.

Multiple A5 sheets produced

Marking progress toward sheet-level fabrication, essential for scaling into demonstrators and eventual commercial deployment.

Energy Ink is being developed in collaboration with a world-class materials science team at the University of New South Wales (UNSW). UNSW is globally recognised for its expertise in functional materials and electronic printing with state-of-the-art nanofabrication, printing and characterisation facilities. The technology has been supported with more than $5 million (USD 3.2 million) in competitive Australian Research Council (ARC) grants, including prestigious ARC Industry Fellowships.

Further Testing

Earlier development showed the low-power, disposable Energy Ink prototype powering a skin patch with two 4 cm × 4 cm cells (32 cm² total area) at 2.5 µW/cm². The transfer fabrication program scaled this performance across thousands of cells.

In the transfer program, 2,051 cells out of 2,052 achieved 100% yield for both open-circuit voltage (>1.2 V) and short-circuit current compliance. A 7-day constant current test of 30 arrays (27 cells in each array) was then conducted at a capped 10 µA per cell to match the skin patch baseline.

All 30 arrays maintained continuous output, each sustaining 270 µA (0.27 mA) for the 7-day period, with minimum power density of 2.5 µW/cm². Testing was performed under semi-controlled indoor humidity of 55%–70% RH, consistent with printed electronics facility environments.

Development Pathway & Challenges

With reproducible fabrication of prototype Energy Ink cells outside the laboratory now achieved, detailed characterisation will be undertaken to establish a robust dataset. The next objectives are to:

  1. Engage international printed electronics centres — to test and develop Energy Ink alongside new materials, packaging, and electrodes. Focus on those with existing commercial relationships.
  2. Initiate discussions with end-user innovation hubs — global companies often run programs for innovative technologies such as battery-free power sources.
  3. Progress toward pilot programs — integrating Energy Ink into demonstrator products to generate data for potential commercial adoption.

Energy Ink remains at an early stage, with challenges ahead:

  • Performance and durability — maintaining stable output over longer periods.
  • Scalability — moving from prototype cells and sheets to larger or stacked formats.
  • Integration — combining effectively with circuits, sensors, and packaging.
  • Timelines — pilot programs may face delays and may not guarantee commercial adoption.

Company Comment

“Congratulations to our team. We look forward to strengthening our relationship with UNSW and collaborating internationally. Deep-tech innovations, especially new power sources, take time to mature but can deliver significant upside. Our Pooled Development Fund structure is designed for this — providing patient capital to capture breakthrough opportunities.” — Charles Murphy, Managing Director, Strategic Elements Strategic Elements.